Advanced Hormone Sensitive Prostate Cancer (DBCOND0072890)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Relugolix	An oral GnRH receptor antagonist for androgen deprivation therapy in the treatment of advanced prostate cancer.	Albumincarrier Alpha-1-acid glycoprotein 1carrier ATP-dependent translocase ABCB1transporter Broad substrate specificity ATP-binding cassette transporter ABCG2transporter Cytochrome P450 3A Subfamilyenzyme Cytochrome P450 2C8enzyme Cytochrome P450 2B6enzyme Gonadotropin-releasing hormone receptortarget

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT02229253	Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer	Degarelix	Not Available	Not Available	completed